company

SON APOTEKLAB AS

1555 SON

Return on Equity
199,72 %
Current Ratio
0,06
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue878 000
Net Income−705 000
Total Assets6 095 000
Total Equity−353 000
Income (NOK)2022
Revenue878 000
Expenditure1 554 000
Operating Profit−577 000
Financial Income0
Financial Costs128 000
Financial Balance−128 000
Earnings Before Tax−705 000
Tax0
Net Income−705 000
Balance (NOK)2022
Total Fixed Assets5 710 000
Total Current Assets385 000
Total Assets6 095 000
Total Retained Equity−383 000
Total Equity−353 000
Total Long-Term Debt0
Total Current Debt6 447 000
Total Equity and Debt6 095 000
Cash flow (NOK)2022
Sales Income878 000
Other Income0
Revenue878 000
Cost of Goods Sold500 000
Salary Costs0
Depreciation480 000
Impairment0
Expenditure1 554 000
Operating Profit−577 000
Financial Income0
Financial Costs128 000
Financial Balance−128 000
Dividends0
Net Income−705 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities1 484 000
Fixtures4 225 000
Total Tangible Assets5 710 000
Total Fiancial Fixed Assets0
Total Fixed Assets5 710 000
Stock100 000
Total Investments0
Cash, Bank55 000
Total Current Assets385 000
Total Assets6 095 000
Total Equity−353 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors31 000
Unpaid Taxes0
Dividends0
Other Current Debt6 416 000
Total Current Debt6 447 000
Total Equity and Debt6 095 000
Financial indicators2022
Return on Equity199,72 %
Debt-to-Equity Ratio−0
Operating Profit Margin−65,72 %
Current Ratio0,06
Quick Ratio0,06
Equity Ratio−0,06
Gross Profit Margin43,05 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English